Barclays Keeps 'Overweight' Rating on Xerox (XRX) After Co. Reiterates Long-Term Goals; Upbeat on Progress
Tweet Send to a Friend
Barclays reiterates an 'Overweight' on Xerox (NYSE: XRX), PT $14.
Barclays analyst says, "Xerox reiterated its FY11 goals and updated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Xerox reiterated its FY11 goals and updated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
